Dendreon Corporation
Latest Dendreon Corporation News
-
Dendreon Falls as Analyst Starts Coverage
Shares of Dendreon Corp . sank Wednesday prostate cancer therapy Provenge will be eclipsed started covering Dendreon shares with an share. Amin said Dendreon is struggling to improve sales of Provenge and he believes
-
Dendreon Falls as Analyst Starts Coverage
Shares of Dendreon Corp . sank Wednesday prostate cancer therapy Provenge will be eclipsed started covering Dendreon shares with an share. Amin said Dendreon is struggling to improve sales of Provenge and he believes
-
Kraft, Emdeon, Chiquita Are Big Market Movers
the average estimate by Wall Street analysts. Nasdaq Dendreon Corp ., down $24.15 at $11.69 Problems plaguing the company's only marketed drug, Provenge , may be deeper than it is acknowledging, industry
-
Oshkosh, Kodak, Blackboard Are Big Market Movers
an investor group led by Providence Equity Partners. Dendreon Corp ., up $1.96 at $41.40 Analysts said the drug Medicare agreed to pay for its prostate cancer therapy Provenge . InterDigital Inc., up $6.12 at $46.87 The
-
Medicare Confirms Payment for Prostate Cancer Drug
prostate cancer drug Provenge , an innovative drug, made by Dendreon Corp ., is a "reasonable label use," of Provenge , the agency concluded analysts estimate Provenge could rack up is important for Dendreon because most prostate
-
Medicare Confirms Payment for Prostate Cancer Drug
prostate cancer drug Provenge , an innovative therapy the biotech drug from Dendreon Corp . is a "reasonable and reimbursement, analysts estimate Provenge could rack up $1 billion decision is important for Dendreon because most prostate
News
-
Medicare to Cover Pricey Prostate Cancer Treatmentindications. Medicare to Cover Provenge for Prostate Cancer MEDCAC the efficacy of off-label Provenge . The company selling the treatment, Dendreon , has indicated it has no it would leave coverage of Provenge for off-label uses to the
-
Provenge Cancer Vaccine: Can You Put a Price on Delaying Death?Washington. Feutz received Provenge in 2007 as part of a clinical prostate cancer adequately. Provenge , unlike his radiation treatments Gold, president and CEO of Dendreon , the company that produces Provenge . "It was a laborious process
-
FDA OKs Vaccine Therapy for Prostate Cancer
would be enough access to Provenge in future months. At the that more men would want Provenge than would be eligible for Winiarski, a spokeswoman for Dendreon Corp ., the company that makes Provenge , said the company would
-
Waiting Game for Life-Extending Prostate Drugto fight their cancer. With Provenge a patient has blood drawn of the research team behind Provenge . "For the people who did Bhardwaj. A spokesman from Dendreon , the company that makes Provenge said the company "has not
-
Provenge Uses Body's Immune System to Fight Prostate CancerThe vaccine, known as Provenge , was developed by Seattle-based Dendreon Corp . It stimulates the body prostate cancer who took Provenge lived 4½ months longer chemotherapy. Besser said Provenge wouldn't be a cure, nor
-
Health Highlights: April 14, 2009
prostate cancer drug Provenge prolonged patient survival Seattle-based drug maker Dendreon Corp . Full data from the advisory panel endorsed Provenge , but the FDA refused Street Journal reported. Provenge triggers the immune system
-
FDA Panel Backs Prostate Cancer Vaccine
found that patients infused with Provenge experienced an average 18 percent 9 months for those receiving Provenge vs. 22 months for those not taking the vaccine. Provenge was developed by Seattle-based Dendreon . "The concept behind the vaccine
